Daratumumab in Detail for Multiple Myeloma with Torben Plesner, MD, Vejle Hospital, Denmark

New Definitions and Treatments of MGUS and Smoldering Myeloma with Pioneer Robert Kyle, MD, Mayo Clinic

MCRI Update on Car T Cell Update by Dr. Michael Hudecek, MD, University of Würzburg, Germany

Benefits of Up-Front Myeloma Transplant and Maintenance Therapy with Dr. Philip McCarthy, Roswell Park Cancer Institute

Boston Round Table - June 25th, 2016

St. Louis Round Table - June 18th, 2016

The Excitement Around Checkpoint Inhibitors in Myeloma with Dr. Don Benson, MD, PhD, Ohio State University

Should Costs be Controlled on the Way to a Cure for Multiple Myeloma? The ICER Report with President Dr. Steven Pearson

The Importance of Proteasome Inhibitors in Myeloma and Their Evolution in the New Age of Myeloma Therapy with Dr. Jacob Laubach, MD, MPP, Dana Farber Cancer Institute